Literature DB >> 14620943

Immunity to measles in the Croatian population.

Berislav Borcić1, Renata Mazuran, Bernard Kaić.   

Abstract

In the frame of measles elimination activities, sera from 1205 Croatian citizens from all parts of the country and of all ages were tested, using Gull Laboratories ELISA, for measles IgG. Equivocal results were found in 50 subjects. Of the remaining 1155 participants, 118 or 10.2% were negative and 1037 or 89.8% positive. The proportion of seronegatives ranged from zero (age groups 41-50, 51 and more) up to 21.4% (1 year of age). As for their distribution into age groups suggested by the European Regional Office of WHO, there were 12.7, 8.9, 9.5 and 8.8% negatives in age groups 1-4, 5-9, 10-14 and 15 + years, respectively. According to these results, only the first two age groups meet WHO criteria, indicating that vaccination coverage higher than the reported 90-94% should be attained if one is to expect measles elimination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620943     DOI: 10.1023/a:1026109201399

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.

Authors:  A Dilraj; F T Cutts; J F de Castro; J G Wheeler; D Brown; C Roth; H M Coovadia; J V Bennett
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

3.  The seroepidemiology of measles in Western Europe.

Authors:  H de Melker; R G Pebody; W J Edmunds; D Lévy-Bruhl; M Valle; M C Rota; S Salmaso; S van den Hof; G Berbers; P Saliou; P Crovari; I Davidkin; G Gabutti; L Hesketh; P Morgan-Capner; A M Plesner; M Raux; A Tische; E Miller
Journal:  Epidemiol Infect       Date:  2001-04       Impact factor: 2.451

4.  An evaluation of nine commercial EIA kits for the detection of measles specific IgG.

Authors:  L Hesketh; A Charlett; P Farrington; E Miller; T Forsey; P Morgan-Capner
Journal:  J Virol Methods       Date:  1997-06       Impact factor: 2.014

5.  The epidemiology of measles in England and Wales since the 1994 vaccination campaign.

Authors:  N Gay; M Ramsay; B Cohen; L Hesketh; P Morgan-Capner; D Brown; E Miller
Journal:  Commun Dis Rep CDR Rev       Date:  1997-02-07

6.  Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-06-13

7.  Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.

Authors:  M Paunio; K Hedman; I Davidkin; M Valle; O P Heinonen; P Leinikki; A Salmi; H Peltola
Journal:  Epidemiol Infect       Date:  2000-04       Impact factor: 2.451

8.  Persistence of measles antibody after revaccination.

Authors:  L E Markowitz; P Albrecht; W A Orenstein; S M Lett; T J Pugliese; D Farrell
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

9.  Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.

Authors:  I Davidkin; M Valle
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

10.  [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].

Authors:  B Borcić; S Smerdel; J Abu Eldan; J Kolić; M Ferdebar; D Kordić; N Mohacek
Journal:  Lijec Vjesn       Date:  1989 Apr-May
View more
  4 in total

1.  Dynamic Features of Herd Immunity: Similarities in Age-Specific Anti-Measles Seroprevalence Data between Two Countries of Different Epidemiological History.

Authors:  Katalin Böröcz; Senka Samardžić; Ines Drenjančević; Ákos Markovics; Tímea Berki; Péter Németh
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

2.  Simultaneous chickenpox and measles infection among migrant children who stayed in Italy during the second half of June 2011.

Authors:  Igor Ivić-Hofman; Ante Cvitković; Bernard Kaić; Tatjana Vilibić-Čavlek; Nenad Pandak; Zorana Marić; Dragana Jurić
Journal:  Clin Pract       Date:  2011-11-10

3.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

4.  Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.

Authors:  Sebastian Funk; Jennifer K Knapp; Emmaculate Lebo; Susan E Reef; Alya J Dabbagh; Katrina Kretsinger; Mark Jit; W John Edmunds; Peter M Strebel
Journal:  BMC Med       Date:  2019-09-25       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.